🇺🇸 FDA
Patent

US 10293049

Etanercept formulations stabilized with amino acids

granted A61KA61K38/17A61K38/1793

Quick answer

US patent 10293049 (Etanercept formulations stabilized with amino acids) held by Coherus BioSciences, Inc. expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Coherus BioSciences, Inc.
Grant date
Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/17, A61K38/1793, A61K38/191, A61K39/39591